868 abstracts found.



Results filter

A study of the relationship between drug efficacy/toxicity and platinum-DNA adduct formation in pre- and post-infusion lymphocyte samples from patients receiving platinum-based chemotherapy

Year:

Session type:

A L Thomas1, A Zayed2, J P Wood1, H Reid2, GDD Jones1, B L Sharp2

1University of Leicester, UK, 2Loughborough University, UK


Plasma phytanic acid concentration and risk of prostate cancer

Year:

Session type:

Alison Price, Naomi Allen, Timothy Key

University of Oxford, UK


Gemcitabine with or without prophylactic weight-adjusted Dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)

Year:

Session type:

Anthony Maraveyas1, Justin Waters2, Rajarshi Roy3, David Propper4, David Fyfe5, Fiona Lofts6, Eric Gardiner1, Joseph Sgouros1, Kevin Wedgwood1

1The Queens Centre for Oncology & Hematology, Hull, UK, 2Kent Oncology Centre, Maidstone Hospital, UK, 3Diana Princess of Wales Hospital, Grimsby, UK, 4St Bartholomews Hospital,, London, UK, 5Royal Lancaster Infirmary, UK, 6St. Georges Hospital Medical School, London, UK


Investigating the link between diet and prostate cancer within the ProtecT trial

Year:

Session type:

Catherine Jameson1, Athene Lane1, Pauline Emmett1, Liz Down1, Marta Tazewell1, Steven Oliver4, Freddie Hamdy3, David Neal2, Jenny Donovan1

1University of Bristol, UK, 2Cambridge University Addenbrookes Hospital, UK, 3University of Oxford, UK, 4University of York, UK


Unplanned hospital admissions as an early surrogate indicator of patient (pt) attrition in phase I trials

Year:

Session type:

Saoirse Dolly

The Institute of Cancer Research, London, UK


A comparison of the UCLA Integrated Staging System (UISS) model and the Leibovich score in survival prediction for patients with non-metastatic clear cell renal cell carcinoma

Year:

Session type:

Tiffany Tang1, Min Tun Nay1, Myo Oo Nay1, Kamalakannan Srimalan1, Caroline Choong2, Vanessa Khoo1, Valerie Khoo1, Tsung Wen Chong2, Puay Hoon Tan2, Min-Han Tan1

1The National Cancer Centre, Singapore, 2Singapore General Hospital, Singapore


A novel role for Nutlin-3 in the mammalian DNA-damage response

Year:

Session type:

Jane Valentine, Sonia Kumar, Abdeladim Moumen

St George's Hospital, University of London, UK


A neurofuzzy model to identify insignificant prostate cancer: development and validation using the ProtecT randomised controlled trial

Year:

Session type:

James Catto1, Maysam Abbod5, Derek Linkens1, Derek Rosario1, Jenny Donovan4, David Neal3, Freddie Hamdy2

1University of Sheffield, UK, 2University of Oxford, UK, 3University of Cambridge, UK, 4University of Bristol, UK, 5Brunel University, London, UK


A two stage multicentre phase II study of Imatinib in the treatment of patients with c-kit positive metastatic uvEal Melanoma (ITEM)

Year:

Session type:

Ernie Marshall1, Carlos Escriu1, Paul Nathan4, S Danson5, M Marples6, Sarah E Coupland2, Catrin Tudur Smith3, Susanna Dodd3, Matthew Bickerstaff3, Bertil Damato2

1Clatterbridge Centre for Oncology, Merseyside, UK, 2Royal Liverpool University Hospital, UK, 3Liverpool Clinical Trials Unit, UK, 4Mount Vernon Hospital, Middlesex, UK, 5Weston Park Hospital, Sheffield, UK, 6St James University Hospital, Leeds, UK


A comparison of MicroRNA profiles in the circulating cells from men with locally confined and advanced prostate cancer

Year:

Session type:

Geetha Laxala1, Freddie Hamdy2, Stephane Larre2, James Catto1

1University of Sheffield, UK, 2University of Oxford, UK


Page 2 of 87« First...2...25...Last »